Researchers prove the usefulness of semen miRNAs as non-invasive biomarkers for prostate cancer
Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital (HUB), show the usefulness of certain molecules , the miRNAs in semen, as non-invasive biomarkers for prostate cancer. […]